how do glp-1 medications work and Anesthesia: Considerations and Cautions for CRNAs Is Zepbound a GLP-1? |

The virtual chronic care provider is now jumping into the GLP-1 market and will start prescribing the drugs in 2026, the company announced Thursday

These studies looked at GLP1-RAs in those with obesity and other comorbidities, without T2D, at weight loss doses

Parenteral administration is expected to dominate the market, accounting for 80% of the market share in 2026, as GLP-1 Receptor Agonists are commonly administered via injections for better absorption and efficacy

Building on the insights from this study, future research should conduct randomized controlled trials comparing pharmacotherapy with and without digital behavioral support to establish causality and quantify the added benefit of digital engagement

Companies are leveraging virtual platforms to: Expand access to obesity treatment nationwide, especially in underserved or rural areas

The Challenge: Persistence and Long-Term Value One of the biggest debates surrounding GLP-1 medications isnt whether they workits whether members stay on therapy long enough to realize projected long-term benefits